Recent Insider Activity at Latigo Biotherapeutics and AdaptHealth Corp.
Sourced from public SEC EDGAR filings. Informational only — not investment advice, and not a recommendation to buy, sell, or hold any security.
Insider Purchases Overview
Recent SEC Form 4 filings report insider purchases at two companies: Latigo Biotherapeutics, Inc. (LTGO) and AdaptHealth Corp. (AHCO).
Latigo Biotherapeutics, Inc. (LTGO)
Filer: Foresite Capital Management V, LLC Role: More than 10% beneficial owner Date of Purchase: 2026-08-10 Shares Purchased: 140,000 Price per Share: $18.00
Foresite Capital Management V, LLC, a beneficial owner of more than 10% of Latigo Biotherapeutics, purchased 140,000 shares at $18.00 per share on August 10, 2026.
AdaptHealth Corp. (AHCO)
Kenneth A. Samet
Role: Director Date of Purchase: 2026-08-06 Shares Purchased: 23,500 Price per Share: $6.38
Kenneth A. Samet, a director of AdaptHealth Corp., purchased 23,500 shares at $6.38 per share on August 6, 2026.
Dale B. Wolf
Role: Director Dates of Purchase: 2026-08-06 and 2026-08-07
Dale B. Wolf, a director of AdaptHealth Corp., purchased 20,000 shares at $6.37 per share on August 6, 2026, and an additional 20,000 shares at $5.86 per share on August 7, 2026.
Sourced directly from Form 4 filings on SEC EDGAR. Not investment advice — see About for what this site does and doesn’t do.